Understanding how the body fights off viruses like SARS-CoV-2
Functional analysis of host and viral determinants for ZAP inhibition
This study is looking at how a protein in our immune system called ZAP helps fight off viruses like SARS-CoV-2, and it hopes to find new ways to create better treatments for viral infections that could help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11056116 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the body's immune response, particularly a protein called ZAP, can inhibit the replication of viruses such as SARS-CoV-2. The study aims to uncover how ZAP interacts with viral components and how some viruses manage to evade this immune response. By exploring these cellular pathways, the research seeks to identify potential targets for developing new antiviral therapies. Patients may benefit from insights that could lead to more effective treatments for viral infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of severe viral infections, particularly those caused by coronaviruses.
Not a fit: Patients with viral infections that do not involve the mechanisms studied, or those who are not at risk for emerging viral infections, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral therapies that effectively combat emerging viral infections.
How similar studies have performed: Other research has shown promise in understanding antiviral mechanisms, but this specific approach to studying ZAP's role is relatively novel.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Melody — University of California Los Angeles
- Study coordinator: Li, Melody
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.